JPMorgan Bullish On Dexcom Heading Into July 21 FDA Panel
June 20, 2016 at 14:04 PM EDT
JPMorgan provided its bullish outlook on DexCom, Inc. (NASDAQ: DXCM) on Monday. The bank believes there is an 80 percent chance of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.